A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Clinical trial NCT05238883 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05238883
Sponsor: HiFiBiO Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Cancer Renal Cell Carcinoma Melanoma Sarcoma Testicular Germ Cell Tumor Cervical Cancer Mesothelioma Non Small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2022-03-10
Primary completion: 2026-12-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.